RTP firm inks potential $46 million deal for cancer treatment in Asia
June 22, 2020 at 14:49 PM EDT
A Triangle drugmaker has inked a deal with a Chinese company for the development and commercialization of its oral cancer drug in Asia, bringing it quick capital and support to push forward its pipeline.
